The global market for CNS Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for CNS Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for CNS Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for CNS Drugs in Hospital and Clinic is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of CNS Drugs include Pfizer, Biogen, Otsuka, Novartis, Teva Pharmaceutical, Johnson & Johnson, AstraZeneca, Merck, GSK, Eli Lilly and Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for CNS Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CNS Drugs.

The CNS Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CNS Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CNS Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CNS Drugs Market Report

Report Metric	Details
Report Name	CNS Drugs Market
Segment by Type	Antidepressants Antipsychotics Anti-Dementia Drugs Anti-Parkinson's Drugs Antiepileptic Drugs Others
Segment by Application	Hospital and Clinic Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Biogen, Otsuka, Novartis, Teva Pharmaceutical, Johnson & Johnson, AstraZeneca, Merck, GSK, Eli Lilly and Company, Lundbeck, Takeda, Bristol Myers Squibb, Jiangsu Nhwa Pharmaceutical, Luye Pharma, Zhejiang Huahai Pharmaceutical, Chengdu Easton Biopharmaceuticals, Hansoh Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CNS Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CNS Drugs Market report?

Ans: The main players in the CNS Drugs Market are Pfizer, Biogen, Otsuka, Novartis, Teva Pharmaceutical, Johnson & Johnson, AstraZeneca, Merck, GSK, Eli Lilly and Company, Lundbeck, Takeda, Bristol Myers Squibb, Jiangsu Nhwa Pharmaceutical, Luye Pharma, Zhejiang Huahai Pharmaceutical, Chengdu Easton Biopharmaceuticals, Hansoh Pharmaceutical

What are the Application segmentation covered in the CNS Drugs Market report?

Ans: The Applications covered in the CNS Drugs Market report are Hospital and Clinic, Pharmacy

What are the Type segmentation covered in the CNS Drugs Market report?

Ans: The Types covered in the CNS Drugs Market report are Antidepressants, Antipsychotics, Anti-Dementia Drugs, Anti-Parkinson's Drugs, Antiepileptic Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CNS Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antidepressants

1.2.3 Antipsychotics

1.2.4 Anti-Dementia Drugs

1.2.5 Anti-Parkinson's Drugs

1.2.6 Antiepileptic Drugs

1.2.7 Others

1.3 Market by Application

1.3.1 Global CNS Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital and Clinic

1.3.3 Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CNS Drugs Market Perspective (2020-2031)

2.2 Global CNS Drugs Growth Trends by Region

2.2.1 Global CNS Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 CNS Drugs Historic Market Size by Region (2020-2025)

2.2.3 CNS Drugs Forecasted Market Size by Region (2026-2031)

2.3 CNS Drugs Market Dynamics

2.3.1 CNS Drugs Industry Trends

2.3.2 CNS Drugs Market Drivers

2.3.3 CNS Drugs Market Challenges

2.3.4 CNS Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CNS Drugs Players by Revenue

3.1.1 Global Top CNS Drugs Players by Revenue (2020-2025)

3.1.2 Global CNS Drugs Revenue Market Share by Players (2020-2025)

3.2 Global CNS Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CNS Drugs Revenue

3.4 Global CNS Drugs Market Concentration Ratio

3.4.1 Global CNS Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CNS Drugs Revenue in 2024

3.5 Global Key Players of CNS Drugs Head office and Area Served

3.6 Global Key Players of CNS Drugs, Product and Application

3.7 Global Key Players of CNS Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CNS Drugs Breakdown Data by Type

4.1 Global CNS Drugs Historic Market Size by Type (2020-2025)

4.2 Global CNS Drugs Forecasted Market Size by Type (2026-2031)

5 CNS Drugs Breakdown Data by Application

5.1 Global CNS Drugs Historic Market Size by Application (2020-2025)

5.2 Global CNS Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America CNS Drugs Market Size (2020-2031)

6.2 North America CNS Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America CNS Drugs Market Size by Country (2020-2025)

6.4 North America CNS Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CNS Drugs Market Size (2020-2031)

7.2 Europe CNS Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe CNS Drugs Market Size by Country (2020-2025)

7.4 Europe CNS Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CNS Drugs Market Size (2020-2031)

8.2 Asia-Pacific CNS Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific CNS Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific CNS Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CNS Drugs Market Size (2020-2031)

9.2 Latin America CNS Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America CNS Drugs Market Size by Country (2020-2025)

9.4 Latin America CNS Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CNS Drugs Market Size (2020-2031)

10.2 Middle East & Africa CNS Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa CNS Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa CNS Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer CNS Drugs Introduction

11.1.4 Pfizer Revenue in CNS Drugs Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Biogen

11.2.1 Biogen Company Details

11.2.2 Biogen Business Overview

11.2.3 Biogen CNS Drugs Introduction

11.2.4 Biogen Revenue in CNS Drugs Business (2020-2025)

11.2.5 Biogen Recent Development

11.3 Otsuka

11.3.1 Otsuka Company Details

11.3.2 Otsuka Business Overview

11.3.3 Otsuka CNS Drugs Introduction

11.3.4 Otsuka Revenue in CNS Drugs Business (2020-2025)

11.3.5 Otsuka Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis CNS Drugs Introduction

11.4.4 Novartis Revenue in CNS Drugs Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Teva Pharmaceutical

11.5.1 Teva Pharmaceutical Company Details

11.5.2 Teva Pharmaceutical Business Overview

11.5.3 Teva Pharmaceutical CNS Drugs Introduction

11.5.4 Teva Pharmaceutical Revenue in CNS Drugs Business (2020-2025)

11.5.5 Teva Pharmaceutical Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson CNS Drugs Introduction

11.6.4 Johnson & Johnson Revenue in CNS Drugs Business (2020-2025)

11.6.5 Johnson & Johnson Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Details

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca CNS Drugs Introduction

11.7.4 AstraZeneca Revenue in CNS Drugs Business (2020-2025)

11.7.5 AstraZeneca Recent Development

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck CNS Drugs Introduction

11.8.4 Merck Revenue in CNS Drugs Business (2020-2025)

11.8.5 Merck Recent Development

11.9 GSK

11.9.1 GSK Company Details

11.9.2 GSK Business Overview

11.9.3 GSK CNS Drugs Introduction

11.9.4 GSK Revenue in CNS Drugs Business (2020-2025)

11.9.5 GSK Recent Development

11.10 Eli Lilly and Company

11.10.1 Eli Lilly and Company Company Details

11.10.2 Eli Lilly and Company Business Overview

11.10.3 Eli Lilly and Company CNS Drugs Introduction

11.10.4 Eli Lilly and Company Revenue in CNS Drugs Business (2020-2025)

11.10.5 Eli Lilly and Company Recent Development

11.11 Lundbeck

11.11.1 Lundbeck Company Details

11.11.2 Lundbeck Business Overview

11.11.3 Lundbeck CNS Drugs Introduction

11.11.4 Lundbeck Revenue in CNS Drugs Business (2020-2025)

11.11.5 Lundbeck Recent Development

11.12 Takeda

11.12.1 Takeda Company Details

11.12.2 Takeda Business Overview

11.12.3 Takeda CNS Drugs Introduction

11.12.4 Takeda Revenue in CNS Drugs Business (2020-2025)

11.12.5 Takeda Recent Development

11.13 Bristol Myers Squibb

11.13.1 Bristol Myers Squibb Company Details

11.13.2 Bristol Myers Squibb Business Overview

11.13.3 Bristol Myers Squibb CNS Drugs Introduction

11.13.4 Bristol Myers Squibb Revenue in CNS Drugs Business (2020-2025)

11.13.5 Bristol Myers Squibb Recent Development

11.14 Jiangsu Nhwa Pharmaceutical

11.14.1 Jiangsu Nhwa Pharmaceutical Company Details

11.14.2 Jiangsu Nhwa Pharmaceutical Business Overview

11.14.3 Jiangsu Nhwa Pharmaceutical CNS Drugs Introduction

11.14.4 Jiangsu Nhwa Pharmaceutical Revenue in CNS Drugs Business (2020-2025)

11.14.5 Jiangsu Nhwa Pharmaceutical Recent Development

11.15 Luye Pharma

11.15.1 Luye Pharma Company Details

11.15.2 Luye Pharma Business Overview

11.15.3 Luye Pharma CNS Drugs Introduction

11.15.4 Luye Pharma Revenue in CNS Drugs Business (2020-2025)

11.15.5 Luye Pharma Recent Development

11.16 Zhejiang Huahai Pharmaceutical

11.16.1 Zhejiang Huahai Pharmaceutical Company Details

11.16.2 Zhejiang Huahai Pharmaceutical Business Overview

11.16.3 Zhejiang Huahai Pharmaceutical CNS Drugs Introduction

11.16.4 Zhejiang Huahai Pharmaceutical Revenue in CNS Drugs Business (2020-2025)

11.16.5 Zhejiang Huahai Pharmaceutical Recent Development

11.17 Chengdu Easton Biopharmaceuticals

11.17.1 Chengdu Easton Biopharmaceuticals Company Details

11.17.2 Chengdu Easton Biopharmaceuticals Business Overview

11.17.3 Chengdu Easton Biopharmaceuticals CNS Drugs Introduction

11.17.4 Chengdu Easton Biopharmaceuticals Revenue in CNS Drugs Business (2020-2025)

11.17.5 Chengdu Easton Biopharmaceuticals Recent Development

11.18 Hansoh Pharmaceutical

11.18.1 Hansoh Pharmaceutical Company Details

11.18.2 Hansoh Pharmaceutical Business Overview

11.18.3 Hansoh Pharmaceutical CNS Drugs Introduction

11.18.4 Hansoh Pharmaceutical Revenue in CNS Drugs Business (2020-2025)

11.18.5 Hansoh Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eli Lilly and Company

Lundbeck

Takeda

Bristol–Myers Squibb

Jiangsu Nhwa Pharmaceutical

Luye Pharma

Zhejiang Huahai Pharmaceutical

Chengdu Easton Biopharmaceuticals

Hansoh Pharmaceutical

Pfizer Inc

Merck

GSK

List of Tables

Table 1. Global CNS Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antidepressants

Table 3. Key Players of Antipsychotics

Table 4. Key Players of Anti-Dementia Drugs

Table 5. Key Players of Anti-Parkinson's Drugs

Table 6. Key Players of Antiepileptic Drugs

Table 7. Key Players of Others

Table 8. Global CNS Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global CNS Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global CNS Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global CNS Drugs Market Share by Region (2020-2025)

Table 12. Global CNS Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global CNS Drugs Market Share by Region (2026-2031)

Table 14. CNS Drugs Market Trends

Table 15. CNS Drugs Market Drivers

Table 16. CNS Drugs Market Challenges

Table 17. CNS Drugs Market Restraints

Table 18. Global CNS Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global CNS Drugs Market Share by Players (2020-2025)

Table 20. Global Top CNS Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Drugs as of 2024)

Table 21. Ranking of Global Top CNS Drugs Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by CNS Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of CNS Drugs, Headquarters and Area Served

Table 24. Global Key Players of CNS Drugs, Product and Application

Table 25. Global Key Players of CNS Drugs, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global CNS Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global CNS Drugs Revenue Market Share by Type (2020-2025)

Table 29. Global CNS Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global CNS Drugs Revenue Market Share by Type (2026-2031)

Table 31. Global CNS Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global CNS Drugs Revenue Market Share by Application (2020-2025)

Table 33. Global CNS Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global CNS Drugs Revenue Market Share by Application (2026-2031)

Table 35. North America CNS Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America CNS Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America CNS Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe CNS Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe CNS Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe CNS Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific CNS Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific CNS Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific CNS Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America CNS Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America CNS Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America CNS Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa CNS Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa CNS Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa CNS Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 50. Pfizer Company Details

Table 51. Pfizer Business Overview

Table 52. Pfizer CNS Drugs Product

Table 53. Pfizer Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 54. Pfizer Recent Development

Table 55. Biogen Company Details

Table 56. Biogen Business Overview

Table 57. Biogen CNS Drugs Product

Table 58. Biogen Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 59. Biogen Recent Development

Table 60. Otsuka Company Details

Table 61. Otsuka Business Overview

Table 62. Otsuka CNS Drugs Product

Table 63. Otsuka Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 64. Otsuka Recent Development

Table 65. Novartis Company Details

Table 66. Novartis Business Overview

Table 67. Novartis CNS Drugs Product

Table 68. Novartis Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 69. Novartis Recent Development

Table 70. Teva Pharmaceutical Company Details

Table 71. Teva Pharmaceutical Business Overview

Table 72. Teva Pharmaceutical CNS Drugs Product

Table 73. Teva Pharmaceutical Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 74. Teva Pharmaceutical Recent Development

Table 75. Johnson & Johnson Company Details

Table 76. Johnson & Johnson Business Overview

Table 77. Johnson & Johnson CNS Drugs Product

Table 78. Johnson & Johnson Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 79. Johnson & Johnson Recent Development

Table 80. AstraZeneca Company Details

Table 81. AstraZeneca Business Overview

Table 82. AstraZeneca CNS Drugs Product

Table 83. AstraZeneca Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 84. AstraZeneca Recent Development

Table 85. Merck Company Details

Table 86. Merck Business Overview

Table 87. Merck CNS Drugs Product

Table 88. Merck Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 89. Merck Recent Development

Table 90. GSK Company Details

Table 91. GSK Business Overview

Table 92. GSK CNS Drugs Product

Table 93. GSK Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 94. GSK Recent Development

Table 95. Eli Lilly and Company Company Details

Table 96. Eli Lilly and Company Business Overview

Table 97. Eli Lilly and Company CNS Drugs Product

Table 98. Eli Lilly and Company Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 99. Eli Lilly and Company Recent Development

Table 100. Lundbeck Company Details

Table 101. Lundbeck Business Overview

Table 102. Lundbeck CNS Drugs Product

Table 103. Lundbeck Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 104. Lundbeck Recent Development

Table 105. Takeda Company Details

Table 106. Takeda Business Overview

Table 107. Takeda CNS Drugs Product

Table 108. Takeda Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 109. Takeda Recent Development

Table 110. Bristol Myers Squibb Company Details

Table 111. Bristol Myers Squibb Business Overview

Table 112. Bristol Myers Squibb CNS Drugs Product

Table 113. Bristol Myers Squibb Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 114. Bristol Myers Squibb Recent Development

Table 115. Jiangsu Nhwa Pharmaceutical Company Details

Table 116. Jiangsu Nhwa Pharmaceutical Business Overview

Table 117. Jiangsu Nhwa Pharmaceutical CNS Drugs Product

Table 118. Jiangsu Nhwa Pharmaceutical Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 119. Jiangsu Nhwa Pharmaceutical Recent Development

Table 120. Luye Pharma Company Details

Table 121. Luye Pharma Business Overview

Table 122. Luye Pharma CNS Drugs Product

Table 123. Luye Pharma Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 124. Luye Pharma Recent Development

Table 125. Zhejiang Huahai Pharmaceutical Company Details

Table 126. Zhejiang Huahai Pharmaceutical Business Overview

Table 127. Zhejiang Huahai Pharmaceutical CNS Drugs Product

Table 128. Zhejiang Huahai Pharmaceutical Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 129. Zhejiang Huahai Pharmaceutical Recent Development

Table 130. Chengdu Easton Biopharmaceuticals Company Details

Table 131. Chengdu Easton Biopharmaceuticals Business Overview

Table 132. Chengdu Easton Biopharmaceuticals CNS Drugs Product

Table 133. Chengdu Easton Biopharmaceuticals Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 134. Chengdu Easton Biopharmaceuticals Recent Development

Table 135. Hansoh Pharmaceutical Company Details

Table 136. Hansoh Pharmaceutical Business Overview

Table 137. Hansoh Pharmaceutical CNS Drugs Product

Table 138. Hansoh Pharmaceutical Revenue in CNS Drugs Business (2020-2025) & (US$ Million)

Table 139. Hansoh Pharmaceutical Recent Development

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

Table 143. Authors List of This Report

List of Figures

Figure 1. CNS Drugs Picture

Figure 2. Global CNS Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CNS Drugs Market Share by Type: 2024 VS 2031

Figure 4. Antidepressants Features

Figure 5. Antipsychotics Features

Figure 6. Anti-Dementia Drugs Features

Figure 7. Anti-Parkinson's Drugs Features

Figure 8. Antiepileptic Drugs Features

Figure 9. Others Features

Figure 10. Global CNS Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global CNS Drugs Market Share by Application: 2024 VS 2031

Figure 12. Hospital and Clinic Case Studies

Figure 13. Pharmacy Case Studies

Figure 14. CNS Drugs Report Years Considered

Figure 15. Global CNS Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global CNS Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global CNS Drugs Market Share by Region: 2024 VS 2031

Figure 18. Global CNS Drugs Market Share by Players in 2024

Figure 19. Global Top CNS Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Drugs as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by CNS Drugs Revenue in 2024

Figure 21. North America CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America CNS Drugs Market Share by Country (2020-2031)

Figure 23. United States CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe CNS Drugs Market Share by Country (2020-2031)

Figure 27. Germany CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific CNS Drugs Market Share by Region (2020-2031)

Figure 35. China CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America CNS Drugs Market Share by Country (2020-2031)

Figure 43. Mexico CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa CNS Drugs Market Share by Country (2020-2031)

Figure 47. Turkey CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE CNS Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 51. Biogen Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 52. Otsuka Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 54. Teva Pharmaceutical Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 55. Johnson & Johnson Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 56. AstraZeneca Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 57. Merck Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 58. GSK Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 59. Eli Lilly and Company Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 60. Lundbeck Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 61. Takeda Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 62. Bristol Myers Squibb Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 63. Jiangsu Nhwa Pharmaceutical Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 64. Luye Pharma Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 65. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 66. Chengdu Easton Biopharmaceuticals Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 67. Hansoh Pharmaceutical Revenue Growth Rate in CNS Drugs Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions